AWA
ALT icon

Arete Wealth Advisors’s Altimmune ALT Stock Holding History

Arete Wealth Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,200
Closed -$137K – 389
2023
Q4 		$137K Buy
+12,200
New +$50.9K 0.01% 697
2023
Q2 		– Sell
-28,427
Closed -$322K – 669
2023
Q1 		$322K Buy
28,427
+4,422
+18% +$52.5K 0.03% 452
2022
Q4 		$264K Buy
+24,005
New +$270K 0.02% 490

Other funds holding ALT

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Arete Wealth Advisors's ALT Position: Q1 2024 in Review

Arete Wealth Advisors sold out of Altimmune (ALT) in Q1 2024, closing a stake of 12,200 shares — an estimated $137K sold.

Arete Wealth Advisors first reported a position in ALT in Q4 2022 and held it in 3 quarters. The position peaked at $322K in Q1 2023. 172 funds tracked by Wall St. Rank hold ALT as of Q1 2024.

  • Arete Wealth Advisors reported no remaining Altimmune position as of Q1 2024 after selling out during the quarter.
  • Arete Wealth Advisors sold 12,200 Altimmune shares in Q1 2024, an estimated $137K.
  • Arete Wealth Advisors first reported a position in Altimmune in Q4 2022 and held it in 3 quarters.
  • Arete Wealth Advisors's Altimmune position peaked at $322K in Q1 2023.
  • 172 funds tracked by Wall St. Rank held Altimmune as of Q1 2024.

Based on Arete Wealth Advisors's 13F filing for Q1 2024, filed 16 May 2024.